Related Articles
EGFR and HER2 signals play a salvage role in MEK1-mutated gastric cancer after MEK inhibition
Combination of BIBW2992 and ARQ 197 is effective against erlotinib-resistant human lung cancer cells with the EGFR T790M mutation
Growth arrest by activated BRAF and MEK inhibition in human anaplastic thyroid cancer cells
Combined use of PI3K and MEK inhibitors synergistically inhibits lung cancer with EGFR and KRAS mutations
Hsp90 inhibitor NVP-AUY922 enhances the radiation sensitivity of lung cancer cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors